{"entity":{"id":"nct06758557","kind":"trial","name":"A Study to Evaluate the Safety and Efficacy of HB0025 Injection in Patients With Advanced Solid Tumor","aka":[],"tldr":"A phase 1/2 trial of Pemetrexed, Paclitaxel / nab-paclitaxel, Carboplatin in endometrial cancer, run by Huabo Biopharm Co., Ltd., now recruiting.","summary":"A Study to Evaluate the Safety and Efficacy of HB0025 Injection in Patients With Advanced Solid Tumor is a phase 1/2 interventional study registered as NCT06758557 by Huabo Biopharm Co., Ltd., with 282 participants planned, started 2024-01-31 and due to reach its primary completion in 2025-10-31. Interventions recorded: HB0025, Pemetrexed, Paclitaxel, Carboplatin. Conditions listed: Advanced NSCLC, Advanced Endometrial Cancer. No results are recorded here; the registry entry is the source.","status":"recruiting","asOf":"2026-09-16","links":[{"label":"ClinicalTrials.gov NCT06758557","url":"https://clinicaltrials.gov/study/NCT06758557"}],"tags":["ctgov-ingest"],"related":[],"cancers":["endometrial"],"sections":[],"technologies":[],"targets":[],"drugs":["pemetrexed","paclitaxel","carboplatin"],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"notes":[],"nct":"NCT06758557","phase":"1/2","setting":"A Multicenter, Open Phase Ib/II Study to Evaluate the Safety, Tolerability, and Preliminary Efficacy of HB0025 Injection Combined With Chemotherapy in Patients With Advanced Solid Tumor","sponsor":"Huabo Biopharm Co., Ltd.","enrolled":282,"outcomes":[]},"route":"/trials/nct06758557/","neighbours":{"cancer":[{"id":"endometrial","kind":"cancer","name":"Endometrial cancer","route":"/cancers/endometrial/"}],"drug":[{"id":"carboplatin","kind":"drug","name":"Carboplatin","route":"/drugs/carboplatin/"},{"id":"paclitaxel","kind":"drug","name":"Paclitaxel / nab-paclitaxel","route":"/drugs/paclitaxel/"},{"id":"pemetrexed","kind":"drug","name":"Pemetrexed","route":"/drugs/pemetrexed/"}]}}